
Novo Nordisk's Wegovy Launch Sparks Weight-Loss Drug Competition in the US
Novo Nordisk has launched Wegovy, a lower-cost, pill-form weight-loss drug in the US, sparking a price war in the sector and offering a needle-free alternative to injectable GLP-1 medications, with significant implications for obesity treatment affordability and accessibility.













